Laurus Labs Ltd - 540222 - Board Meeting Outcome for Outcome Of The Board Meeting - 28.04.2022
Outcome of the Board Meeting - 28.04.202228-04-2022
28-04-2022
Laurus Labs Ltd - 540222 - Approval Of Audited Financial Results For The Year Ended March 31, 2022 And Limited Reviewed Financial Results For The Quarter Ended March 31, 2022
Approval of audited Financial Results for the Year ended March 31, 2022 and Limited Reviewed Financial Results for the Quarter ended March 31, 202228-04-2022
Laurus Labs Ltd - 540222 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayLaurus Labs Ltd 2CINL24239AP2005PLC047518 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 505.98 4Highest Credit Rating during the previous FY AA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: G VENKATESWAR REDDY Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: secretarial@lauruslabs.com Name of the Chief Financial Officer: V V RAVI KUMAR Designation: EXECUTIVE DIRECTOR AND CFO EmailId: secretarial@lauruslabs.com Date: 28/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.28-04-2022
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
LAURUS LABS LTD. Q4 & FULL YEAR FY22 RESULTS CONFERENCE CALL ON FRIDAY, APRIL 29, 2022 AT 11:00 AM IST25-04-2022
Laurus Labs Ltd - 540222 - Board Meeting Intimation for To Consider And Approve The Audited Financial Results And To Declare 2Nd Interim Dividend For FY 2021-22
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday, April 28, 2022, inter-alia: -.,. to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2022; -,. to consider the proposal for payment of 2nd Interim Dividend for FY 2021-22 and fixation of record date for determining the eligibility of shareholders (if approved). Further, the Company''s trading window for dealing in securities by the Directors and Designated Persons has been closed from Friday, April 01, 2022, which was already intimated on March 30, 2022, and shall continue to remain closed till Saturday, April 30, 2022 (both days inclusive). This is for your information and records.21-04-2022
Growth trajectory, margins anc client additions to sustain for Laurus Labs
Some of the growth is captured in the price rally, higher valuations19-04-2022
Laurus Labs Ltd - 540222 - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations 2015
Certificate under Regulation 40(9) of SEBI (LODR) Regulations 201507-04-2022
Laurus Labs Ltd - 540222 - Compliance Certificate For The Year Ended March 31, 2022 Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015
Compliance Certificate for the Year Ended March 31, 2022 under Regulation 7(3) of SEBI (LODR) Regulations, 201507-04-2022
Laurus Labs Ltd - 540222 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- G Venkateswar ReddyDesignation :- Company Secretary and Compliance Officer07-04-2022